Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Adnan A. Alseidi
Sustained CA19-9 Response to Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Cancer Predicts Progression and Survival
Oncologist
Cancer Research
Medicine
Oncology
Related publications
Erratum To: Extended Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer Demonstrates Promising Postoperative Outcomes and Survival
Annals of Surgical Oncology
Oncology
Surgery
A Pilot Study- Neoadjuvant Chemotherapy With Gemcitabine and S1 in Patients With Resectable and Borderline Resectable Pancreatic Cancer
Journal of Carcinogenesis & Mutagenesis
Target Capture RNA Sequencing as a Method of Predicting Response to Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Cancer: A Multi-Institutional Study
HPB
Hepatology
Gastroenterology
Preoperative Nomogram to Predict Survival for Patients With Resectable and Borderline Resectable Pancreatic Cancer
HPB
Hepatology
Gastroenterology
Complete Pathological Response Following Neoadjuvant FOLFIRINOX in Borderline Resectable Pancreatic Cancer - A Case Report and Review
BMC Cancer
Cancer Research
Oncology
Genetics
Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials
Journal of Clinical Medicine
Operative Outcomes Following Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy (Sbrt) for Borderline Resectable and Locally Advanced Pancreatic Cancer
HPB
Hepatology
Gastroenterology
Meta-Analysis Comparing Upfront Surgery With Neoadjuvant Treatment in Patients With Resectable or Borderline Resectable Pancreatic Cancer
British Journal of Surgery
Surgery
Management of Borderline Resectable Pancreatic Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
